Sablich Kim's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Jun 8, 2022
- Accession no.
- 0001765581-22-000057
- Filed
- Jun 8, 2022
- Trade date
- Jun 6-7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $579.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sablich KimCIK 0001758790 | Officer (EVP & GM, North America) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Ordinary Shares | FTax withholdingDisposed | −1,759 | $149.25 | −$262,530.75 | 28,583 | Direct | |
| Jun 6, 2022 | Ordinary Shares | SSaleDisposed | −1,388 | $152.15 | −$211,184.2 | 27,195 | Direct | |
| Jun 7, 2022 | Ordinary Shares | SSaleDisposed | −200 | $148.21F3 | −$29,642 | 26,995 | Direct | |
| Jun 7, 2022 | Ordinary Shares | SSaleDisposed | −250 | $149.22F4 | −$37,305 | 26,745 | Direct | |
| Jun 7, 2022 | Ordinary Shares | SSaleDisposed | −573 | $150.68F5 | −$86,339.64 | 26,172 | Direct | |
| Jun 7, 2022 | Ordinary Shares | SSaleDisposed | −1,317 | $151.87F6 | −$200,012.79 | 24,855 | Direct | |
| Jun 7, 2022 | Ordinary Shares | SSaleDisposed | −101 | $152.60F7 | −$15,412.6 | 24,754 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.05 to $148.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.12 to $149.70. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.32 to $151.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F6
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $151.35 to $152.21. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.595 to $152.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.